New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
10:01 EDTWLT, PNRA, MAR, FLIR, DPSGY, CTL, USG, NABZY, VLCCF, DWA, CVLT, WAIR, SQM, MFRM, HVRRY, DEO, CLH, APD, BCE, AGNOn The Fly: Analyst Downgrade Summary
Air Products (APD) downgraded to Underweight from Neutral at Atlantic Equities... Allergan (AGN) downgraded to Hold from Buy at Stifel... BCE (BCE) downgraded to Sector Perform from Outperform at RBC Capital... CenturyLink (CTL) downgraded to Market Perform from Outperform at BMO Capital... Clean Harbors (CLH) downgraded to Outperform from Strong Buy at Raymond James... CommVault (CVLT) downgraded to Neutral from Buy at Monness Crespi... Deutsche Post (DPSGY) downgraded to Equalweight from Overweight at Barclays... Diageo (DEO) downgraded to Neutral from Outperform at Credit Suisse... DreamWorks Animation (DWA) downgraded to Underperform from Neutral at BofA/Merrill... FLIR Systems (FLIR) downgraded to Fair Value from Buy at CRT Capital... Hannover Re (HVRRY) downgraded to Underperform from Neutral at BofA/Merrill... Knightsbridge Tankers (VLCCF) downgraded to Equal Weight at Morgan Stanley... Marriott (MAR) downgraded to Neutral from Buy at SunTrust... Mattress Firm (MFRM) downgraded to Hold from Buy at KeyBanc... National Australia Bank (NABZY) downgraded to Sell from Neutral at Citigroup... Panera Bread (PNRA) downgraded to Underperform from Neutral at Longbow... Sociedad Quimica (SQM) downgraded to Underweight from Neutral at HSBC... USG (USG) downgraded to Equalweight from Overweight at Barclays... Walter Energy (WLT) downgraded to Market Perform from Outperform at Clarkson... Wesco Aircraft (WAIR) downgraded to Neutral from Overweight at JPMorgan.
News For APD;AGN;BCE;CTL;CLH;CVLT;DPSGY;DEO;DWA;FLIR;HVRRY;VLCCF;MAR;MFRM;NABZY;PNRA;SQM;USG;WLT;WAIR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
February 18, 2015
16:36 EDTMARMarriott sees FY15 EPS $3.00-$3.12, consensus $3.03
Subscribe for More Information
16:34 EDTMARMarriott sees Q1 EPS 68c-72c, consensus 66c
For Q1, the company expects comparable systemwide RevPAR on a constant dollar basis will increase 5 to 7% in North America, 4 to 6% outside North America and 5 to 7% worldwide.
16:33 EDTMARMarriott reports Q4 EPS 68c, consensus 65c
Subscribe for More Information
15:35 EDTMARNotable companies reporting after market close
Subscribe for More Information
12:31 EDTAGNOn The Fly: Midday Wrap
Subscribe for More Information
10:05 EDTCTLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:48 EDTAGNActavis Q4 'exceptional,' taking Allergan name 'wise,' says BMO Capital
BMO Capital says Actavis (ACT) is "firing on all cylinders" after reporting "exceptional" Q4 earnings on the strength of the company's North American Generics and International segment. BMO views the decision to adopt the Allergan (AGN) name as "wise" given the Botox maker's strong reputation. The firm keeps an Outperform rating on Actavis.
09:10 EDTMARMarriott volatility increases into Q4 results and outlook
Marriott overall option implied volatility of 25 is near its 26-week average of 23 according to Track Data, suggesting non-directional price movement into the expected release of Q4 on February 19.
09:10 EDTCTLOn The Fly: Pre-market Movers
Subscribe for More Information
07:50 EDTAGNActavis CEO says company gave appropriate guidance to analysts
Actavis (ACT) CEO Saunders said he believes that the company did provide appropriate guidance to analysts ahead of its earnings beat. Saunders sees the Allergan (AGN) deal closing by the end of this quarter or early next quarter. Saunders says tying R&D to a percentage of revenue "makes no sense to me," noting that Actavis will spend about $1.7B on R&D next year. Saunders says will do acquisition if opportunity arises, but not planning for M&A right now. Actavis CEO Brent Saunders is speaking on CNBC.
07:01 EDTAGNActavis announces intention to adopt 'Allergan' corporate name
Subscribe for More Information
06:34 EDTAGNActavis sees Allergan transaction completed in late Q1 or early Q2
05:31 EDTCTLCenturyLink downgraded to Sell from Neutral at Goldman
Subscribe for More Information
February 17, 2015
18:06 EDTAGNPaulson & Co gives quarterly update on stakes
Subscribe for More Information
17:18 EDTAGNPershing Square gives quarterly update on stakes
NEW STAKES: Restaurant Brands International (QSR). INCREASED STAKES: Zoetis (ZTS), and Platform Specialty Products (PAH). DECREASED STAKES: Allergan (AGN). LIQUIDATED STAKES: None.
17:02 EDTAGNSoros Fund Management gives quarterly update on stakes
Subscribe for More Information
13:52 EDTAGNEarnings Preview: Actavis near 52-week high ahead of Q4 earnings report
Subscribe for More Information
09:20 EDTWLTOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Vipshop Holdings (VIPS), up 10.9%... VASCO Data Security (VDSI), up 7.1%... Waste Management (WM), up 3.7%. ALSO HIGHER: Starwood Hotels (HOT), up 1.9% after appointing Adam Aron as interim CEO... Sarepta Therapeutics (SRPT), up 7.3% after being upgraded at BofA/Merrill... Navidea Biopharmaceuticals (NAVB), up 7.5% after publishing results of phase 3 Lymphoseek trial... Campus Crest (CCG), up 7.7% after announcing that it will explore strategic alternatives as well as Clinton Group and Campus Evolution proxy contest... Cyren (CYRN), up 7.1% following distribution agreement with ALSO Deutschland. DOWN AFTER EARNINGS: Helix Energy (HLX), down 13.3%... Walter Energy (WLT), down 10.1%. ALSO LOWER: Celsus Therapeutics (CLTX), down 82.3% after MRX-6 Cream 2% Phase II trial did not meet primary endpoint... Vascular Biogenics (VBLT), down 53.2% after reporting that VB-201 Phase 2 studies did not meet primary endpoints and removal of FDA partial clinical hold on VB-111... Vanguard Natural Resources (VNR), down 7.1% after reporting preliminary fourth quarter results.
07:38 EDTWLTWalter Energy expects met coal sales 8.5 MMT-9.0 MMT
Walter Energy expects met coal sales to total 8.5 to 9.0 MMTs in 2015. Capital expenditures in 2015 are expected to be in line with 2014, and the company expects to further reduce SG&A expenses by 10%. Cash interest expense is expected to approximate $265M for the year.
07:36 EDTWLTWalter Energy reports Q4 adjusted EPS ($1.97), consensus ($1.59)
Reports Q4 revenue $285.56M, consensus $326.55M.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use